The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

Freshfields represented Moderna, while Taylor Wessing advised BioNTech and Munich IP-firm df-mp was counsel to Pfizer.

The next-generation cost needs to be added to the long-term effects on vaccinees. Yet, Dr. Hatfill writes, the American College of Obstetrics and Gynecology (ACOG) has continued to promote the mass ...

On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 3103.07 with a total volume of 1,821.00. In the following chart, we are able to follow the development of ...

The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

Legislation aimed to ban or limit mRNA vaccines was introduced this year by GOP lawmakers in at least seven states.

A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...

Freshfields has won a Düsseldorf regional court patent dispute on behalf of client Moderna against German COVID-19 vaccine ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it’s ...